Results 31 to 40 of about 61,154,629 (172)

Long‐Acting PrEP for People With High Vulnerability to HIV Acquisition in Brazil: A Cost‐Effectiveness Analysis

Journal of the International AIDS Society, Volume 29, Issue 5, May 2026.
ABSTRACT Introduction In Brazil, men who have sex with men (MSM) and transgender women (TGW) remain heavily affected by HIV. Long‐acting pre‐exposure prophylaxis (LA PrEP) with injectable cabotegravir (CAB‐LA) or lenacapavir (LEN‐LA) is more effective at preventing HIV acquisition than oral PrEP.
Wanyi Chen, Paula M. Luz, Anjali Srinivasan, Beatriz Grinsztejn, Justine A. Scott, Anne M. Neilan, Valdiléa G. Veloso, Caitlin M. Dugdale, Kenneth A. Freedberg   +8 more
wiley   +1 more source

Avances y limitaciones en la investigación sobre factores sociales relativosa la Migración y Chagas

Humanidades Médicas, 2021
Este artículo presenta los resultados de una revisión bibliográfica sistemática en relación con las últimas investigaciones académicas sobre enfermedad de Chagas, población migrante y determinantes sociales.
Galaz Valderrama, Caterine, Avaria Saavedra, Andrea, Silva Dittborn, Claudia   +2 more
doaj  

Isolation of Extracellular Vesicles From Gram‐Negative Bacteria: A Solid Medium‐Based Method Analysis

Journal of Extracellular Biology, Volume 5, Issue 4, April 2026.
ABSTRACT Extracellular vesicles (EVs) produced by gram‐negative bacteria have gained increased scientific interest over the last years due to a growing understanding of their roles in pathogenesis and biotechnological potential. However, isolating such nanoparticles is technically challenging. Here, we evaluated a rapid and reproducible protocol for EV
Roberto G. M. Guardatti, Jhonatha R. Cordeiro‐Moura, Jhon J. Artunduaga Bonilla, Stefanie C. da Costa, Anderson S. Cabral, Bruna Montalvão, Flávia G. C. Reis, Leonardo Nimrichter, Márcio L. Rodrigues, Juliana Rizzo, Renata C. Picão   +10 more
wiley   +1 more source

Evaluación de dos pruebas inmunocromatográficas para el diagnóstico de la enfermedad de Chagas

Anales de la Facultad de Medicina
Introducción. La tripanosomiasis americana es una enfermedad parasitaria desatendida que afectaría entre siete y ocho millones de personas principalmente en 21 países de las Américas, incluido el Perú.
William Cornejo, Pilar Alva, William Roldán, Irma Espinoza, Nancy Ruelas   +4 more
doaj   +1 more source

Evaluación preliminar de la prueba comercial Chagas (Trypanosoma cruzi) IgG-ELISA® en individuos colombianos

Biomédica: revista del Instituto Nacional de Salud, 2014
Introducción. El diagnóstico de la enfermedad de Chagas es fundamental para brindar un tratamiento oportuno y mejorar el pronóstico del paciente.
Mónica Llano, Paula Pavía, Astrid Carolina Flórez, Adriana Cuéllar, John Mario González, Concepción Judith Puerta   +5 more
doaj   +1 more source

Successional and native forests predict the occurrence and infection status of Chagas disease vectors in Panama

Journal of Applied Ecology, Volume 63, Issue 1, January 2026.
Findings here show that successional forest predicts greater kissing bug infestation risk in palm trees, whereas native forest predicts lower kissing bug occurrence but greater infection with T. cruzi. These insights can guide land use planning towards vegetation management practices that help minimize T. cruzi transmission risks for rural communities.
Juliana Hoyos, Azael Saldaña, Sonia Altizer, Vanessa Pineda, Kadir Gonzalez, Jose E. Calzada, Raissa Nogueira de Brito, Susan Tanner, Daniel Mendieta, Alberto Cumbrera, Nicole L. Gottdenker   +10 more
wiley   +1 more source

Enfermedad de chagas en perros : una revisión [PDF]

, 2019
32 páginas : ilustraciones, gráficasChagas disease or american trypanosomiasis, caused by the flagellated protozoan Trypanosoma cruzi and transmitted mainly in a vectorial way by triatomines, is a zoonotic endemic disease and a public health problem in ...
Peña Sánchez, Alexandra
core   +3 more sources

Tratamento da Doença de Chagas pelo Nifurtimox (Bayer 2502)

Revista da Sociedade Brasileira de Medicina Tropical, 1975
Foram tratados 77 pacientes com doença de Chagas pelo nifurtimox, subdivididos em quatro grupos. Grupo I, com 30 pacientes na fase aguda. Somente oito doentes usaram a droga durante 120 dias, na dose inicial de 15 mg/kg de peso corporal e posteriormente ...
Aluizio Prata, Vanize Macêdo, Gildete Porto, Iracema Santos, José A. Cerisola, Neiron Silva   +5 more
doaj   +1 more source

Natural Products from Mexican Medicinal Plants as Promising Trypanocidal Drugs

ChemistrySelect, Volume 10, Issue 37, October 6, 2025.
Chagas disease (American Trypanosomiasis) is caused by the protozoan Trypanosoma cruzi. Worldwide it is one of the seventeen neglected tropical diseases. There is a need of new drugs. This review assesses the literature (2012‐2024) of secondary metabolites isolated from Mexican plants active against this parasite.
Karla Daniela Rodríguez‐Hernández, Elia Guadalupe Jaimes‐Castelán, Ricardo Reyes‐Chilpa   +2 more
wiley   +1 more source

The ecology and genetics of Chagas disease vectors in Ecuador, with emphasis on Rhodnius ecuadoriensis (Hemiptera : Reduviidae : Triatominae) [PDF]

An estimate >11 million people are infected by Trypanosoma cruzi in Latin America. Chagas disease control programmes have been successful in the Southern Cone countries, and similar initiatives are underway in the Andean ...
Abad-Franch, Fernando
core   +1 more source